Mycology and Eukaryotic Microbiology Sessions

By focusing directly on human-microbe interactions and therapeutic innovation, this track bridges fundamental eukaryotic pathogen research with clinical application, uncovering how fungal communities shape systemic health and how next-generation antimicrobials can overcome evolving resistance.

Key Main Learning Outcomes

By participating in these sessions, you will:

Evaluate molecular mechanisms of eukaryotic pathogenesis and explore innovative therapeutic strategies to combat antifungal resistance.
Assess the complex roles of human-associated fungal communities (the mycobiome) in maintaining homeostasis and driving systemic diseases.
Discover translational approaches for targeting eukaryotic virulence pathways in clinical environments.

MEM Sessions - Day 1

Eukaryotic Pathogens and Antimicrobials

📅 Wed, 04.11.2026 | 🕦 11:30 - 13:00

This session will showcase the latest discoveries of new compounds and innovative clinical applications designed to combat resistant eukaryotic diseases

Learn more